Pinnacle Financial Partners (Tennessee)’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-450
Closed -$103K 552
2025
Q1
$103K Hold
450
﹤0.01% 466
2024
Q4
$110K Hold
450
﹤0.01% 460
2024
Q3
$110K Hold
450
﹤0.01% 459
2024
Q2
$89.1K Hold
450
﹤0.01% 465
2024
Q1
$89.1K Hold
450
﹤0.01% 460
2023
Q4
$77.4K Hold
450
﹤0.01% 444
2023
Q3
$66.5K Hold
450
﹤0.01% 422
2023
Q2
$98.3K Hold
450
﹤0.01% 417
2023
Q1
$98.5K Hold
450
﹤0.01% 407
2022
Q4
$93.7K Hold
450
﹤0.01% 392
2022
Q3
$98K Buy
+450
New +$102K ﹤0.01% 376

Other funds holding RMD

Pinnacle Financial Partners (Tennessee)'s RMD Position: Q2 2025 in Review

Pinnacle Financial Partners (Tennessee) sold out of ResMed (RMD) in Q2 2025, closing a stake of 450 shares — an estimated $103K sold.

Pinnacle Financial Partners (Tennessee) first reported a position in RMD in Q3 2022 and held it in 11 quarters. The position peaked at $110K in Q4 2024. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

  • Pinnacle Financial Partners (Tennessee) reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
  • Pinnacle Financial Partners (Tennessee) sold 450 ResMed shares in Q2 2025, an estimated $103K.
  • Pinnacle Financial Partners (Tennessee) first reported a position in ResMed in Q3 2022 and held it in 11 quarters.
  • Pinnacle Financial Partners (Tennessee)'s ResMed position peaked at $110K in Q4 2024.
  • 919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q2 2025, filed 28 Oct 2025.